Colestipol and Cholestyramine Resin
Authors:
- Charles J. GlueckCGCharles J. Glueck
- Starr FordSFStarr Ford
- Deborah ScheelDSDeborah Scheel
- Paula SteinerPSPaula Steiner
- 6 November 1972
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 222 (6) , 676-681
Abstract
Two bile acid-sequestrant anion exchange resins, colestipol (U-26, 597A) and cholestyramine resin (Questran), were given in doses of 20 gm/day for four months each in a 14-month placebo crossover study to 25 patients with familial type II hyperlipoproteinemia. Plasma cholesterol and β-lipoprotein cholesterol were reduced to normal levels in 20 and 22 subjects, respectively, by one or both drugs. Coupled with low cholesterol, low saturated fat, polyunsaturate-rich diet, colestipol and cholestyramine provide parallel and alternative approaches to normalization of cholesterol and β-lipoprotein cholesterol in familial type II hyperlipoproteinemia.Keywords
This publication has 10 references indexed in Scilit:
- Semiautomated Fluorometric Measurement of Triglycerides ,1972
- Treatment of the Hyperlipidemic States With Special Emphasis On the Place of Cholestyramine in TherapyAngiology, 1970
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970
- Hypoprothrombinemia and Hemorrhage Associated with Cholestyramine TherapyAnnals of Internal Medicine, 1970
- Intestinal Obstruction Associated with Cholestyramine TherapyNew England Journal of Medicine, 1969
- A comparison of heritable abnormal lipoprotein patterns as defined by two different techniquesJournal of Clinical Investigation, 1968
- Effect of Glycodiazine on Blood Sugar in Diabetes MellitusDiabetes, 1968
- Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patientJournal of Clinical Investigation, 1968
- Turnover of plasma cholesterol in manJournal of Clinical Investigation, 1968
- The Effect of Cholestyramine on Fecal Excretion of Ingested Radioiodinated LipidsThe American Journal of Clinical Nutrition, 1966